3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Warts
1
Neutropenia
1
Myeloproliferative Disorders
1
Myelodysplastic Syndromes
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Mantle-Cell
1
Lymphoma, Follicular
1
Leukopenia
1
Leukemia, Plasma Cell
1
Leukemia, Myeloid, Acute
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Infections
1
Immunologic Deficiency Syndromes
1
Hematologic Neoplasms
1
Agammaglobulinemia
1
Acquired Immunodeficiency Syndrome
1
Interventions
Cyclophosphamide
17
fludarabine phosphate
12
pembrolizumab
11
Brentuximab Vedotin
11
Nivolumab
10
Mycophenolic Acid
10
fludarabine
9
Doxorubicin
9
Dacarbazine
9
Whole-Body Irradiation
8
Vinblastine
7
Magnetic Resonance Spectroscopy
7
Filgrastim
7
Etoposide
7
Cyclosporine
7
Specimen Handling
6
Sirolimus
5
Radiotherapy
5
Peripheral Blood Stem Cell Transplantation
5
Melphalan
5
Granulocyte Colony-Stimulating Factor
5
Busulfan
5
Tacrolimus
4
Gemcitabine
4
pegfilgrastim
3
Vinorelbine
3
Radiation
3
Cyclosporins
3
Carmustine
3
thymoglobulin
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Hodgkin Disease
×
plerixafor
×
90 days
×
Clear all
No trials found.